Evidence map›Paper›PMID 33439121›Full record

ArticleeLife2021

Thymic stromal lymphopoietin limits primary and recall CD8

Risa Ebina-Shibuya, Erin E West, Rosanne Spolski, Peng Li, Jangsuk Oh, Majid Kazemian, Daniel Gromer, Phillip Swanson, Ning Du, Dorian B McGavern and 1 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. TSLP: contrasting roles in cancer.Frontiers in immunology · 2025
    Review
  7. Review
  8. Severe Asthmatic Responses: The Impact of TSLP.International journal of molecular sciences · 2023
    Review
  9. Review
  10. TSLP, IL-33, and IL-25: Not just for allergy and helminth infection.The Journal of allergy and clinical immunology · 2022
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Risa Ebina-Shibuya *Laboratory of Molecular Immunology, Immunology Center, National Heart, Lung, and Blood Institute National Institutes of Health, Bethesda, United States.ORCID 0000-0001-9031-5070
Erin E West *Laboratory of Molecular Immunology, Immunology Center, National Heart, Lung, and Blood Institute National Institutes of Health, Bethesda, United States.
Rosanne SpolskiLaboratory of Molecular Immunology, Immunology Center, National Heart, Lung, and Blood Institute National Institutes of Health, Bethesda, United States.
Peng LiLaboratory of Molecular Immunology, Immunology Center, National Heart, Lung, and Blood Institute National Institutes of Health, Bethesda, United States.
Jangsuk OhLaboratory of Molecular Immunology, Immunology Center, National Heart, Lung, and Blood Institute National Institutes of Health, Bethesda, United States.
Majid KazemianLaboratory of Molecular Immunology, Immunology Center, National Heart, Lung, and Blood Institute National Institutes of Health, Bethesda, United States.ORCID 0000-0001-7080-8820
Daniel GromerLaboratory of Molecular Immunology, Immunology Center, National Heart, Lung, and Blood Institute National Institutes of Health, Bethesda, United States.
Phillip SwansonViral Immunology & Intravital Imaging Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, United States.
Ning DuLaboratory of Molecular Immunology, Immunology Center, National Heart, Lung, and Blood Institute National Institutes of Health, Bethesda, United States.
Dorian B McGavernViral Immunology & Intravital Imaging Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, United States.
Warren J LeonardLaboratory of Molecular Immunology, Immunology Center, National Heart, Lung, and Blood Institute National Institutes of Health, Bethesda, United States.ORCID 0000-0002-5740-7448
National Institutes of Health · US

Funding

Mechanisms Underlying Clearance of the Persistently Infected CNSZIANS003111 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI MCGAVERN, DORIAN · 2009 to 2025
$33.0M
IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP SystemsZIAHL005409 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LEONARD, WARREN J · 2009 to 2025
$10.0M
Expression, regulation, and role of enhancer RNAs in T helper cellsK22HL125593 · NHLBI · PURDUE UNIVERSITY · PI KAZEMIAN, MAJID · 2017 to 2019
$747k
NHLBI NIH HHS K22 HL125593
6 · The paper itself

Abstract

Thymic stromal lymphopoietin (TSLP) is a cytokine that acts directly on CD4

Indexed as

AnimalsCD8-Positive T-LymphocytesCytokinesFemaleLymphocytic choriomeningitis virusMiceMice, Inbred C57BLOrthomyxoviridaeThymic Stromal LymphopoietinCytokinesThymic Stromal LymphopoietinCD8immunologyinflammationmemorymouseT cellTSLPviral infection

Identifiers

PMID33439121
PMCPMC7806261
OpenAlexW3119699708

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.